189 related articles for article (PubMed ID: 35815452)
21. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
22. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection.
Ueda N; Kawaoka T; Imamura M; Aikata H; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Hayes CN; Yokozaki M; Chayama K
BMC Gastroenterol; 2020 Sep; 20(1):314. PubMed ID: 32977741
[TBL] [Abstract][Full Text] [Related]
23. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF
Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.
Okuda Y; Taura K; Yoshino K; Ikeno Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Hatano E; Tanaka S; Uemoto S
Ann Surg; 2017 Jun; 265(6):1201-1208. PubMed ID: 27355265
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the efficacy of the gadoxetic acid MRI-derived relative enhancement index (REI) and functional liver imaging score (FLIS) in predicting liver function: validation with Albumin-Bilirubin (ALBI) grade.
Eryuruk U; Tasdemir MN; Karasu HI; Aslan S
Abdom Radiol (NY); 2024 May; 49(5):1456-1466. PubMed ID: 38653813
[TBL] [Abstract][Full Text] [Related]
26. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer.
Hur M; Park M; Moon HW; Choe WH; Lee CH
Ann Lab Med; 2022 Mar; 42(2):249-257. PubMed ID: 34635616
[TBL] [Abstract][Full Text] [Related]
28. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
[TBL] [Abstract][Full Text] [Related]
29. Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease.
Tangvoraphonkchai K; Suttichaimongkol T; Kularbkaew C; Sangaimwibool P; Sukeepaisarnjaroen W
Sci Rep; 2022 Apr; 12(1):6757. PubMed ID: 35474106
[TBL] [Abstract][Full Text] [Related]
30. Mac-2-binding protein glycosylation isomer is useful to predict muscle cramps in patients with chronic liver disease.
Miwa T; Hanai T; Sakai Y; Kochi T; Katsumura N; Shimizu M
Medicine (Baltimore); 2022 Oct; 101(41):e31145. PubMed ID: 36254085
[TBL] [Abstract][Full Text] [Related]
31. Modification of the ALBI-PLT Score for the Prediction of High-risk Varices.
Inoue-Yuri M; Enomoto H; Wakabayashi I; Yuri Y; Aizawa N; Ikeda N; Takashima T; Fujiwara A; Yoshioka R; Kawata S; Yoshihara K; Ota S; Nakano R; Shiomi H; Nishimura T; Nishiguchi S; Iijima H
In Vivo; 2022; 36(3):1360-1366. PubMed ID: 35478164
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy: A case controlled study.
Hiyoshi M; Yano K; Nanashima A; Ikenoue M; Imamura N; Fujii Y; Hamada T; Nishida T
Ann Med Surg (Lond); 2019 Dec; 48():17-22. PubMed ID: 31692665
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
Nah EH; Cho S; Kim S; Kim HS; Cho HI
J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
[TBL] [Abstract][Full Text] [Related]
34. Serum angiopoietin-2 levels predict regression of Mac-2 binding protein glycosylation isomer-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
Suzuki T; Matsuura K; Nagura Y; Ogawa S; Fujiwara K; Nojiri S; Watanabe T; Kataoka H; Tanaka Y
Hepatol Res; 2022 Nov; 52(11):919-927. PubMed ID: 35938598
[TBL] [Abstract][Full Text] [Related]
35. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
[TBL] [Abstract][Full Text] [Related]
36. Serum Mac-2 binding protein glycosylation isomer as a biomarker of fibrosis in living donor liver transplant graft.
Sasaki R; Miyaaki H; Narita S; Fukushima M; Haraguchi M; Miuma S; Hidaka M; Eguchi S; Okudaira S; Abe K; Nakao K
Clin Transplant; 2021 Feb; 35(2):e14175. PubMed ID: 33247961
[TBL] [Abstract][Full Text] [Related]
37. Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients.
Wu PS; Hsieh YC; Lee KC; Huang YH; Hou MC; Lin HC
PLoS One; 2021; 16(10):e0258589. PubMed ID: 34648567
[TBL] [Abstract][Full Text] [Related]
38. Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.
Morio K; Imamura M; Daijo K; Teraoka Y; Honda F; Nakamura Y; Kobayashi T; Nakahara T; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Kawakami Y; Aikata H; Nelson Hayes C; Tsugawa K; Yokozaki M; Chayama K
J Gastroenterol; 2017 Dec; 52(12):1252-1257. PubMed ID: 28477171
[TBL] [Abstract][Full Text] [Related]
39. The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury.
Seike T; Komura T; Shimizu Y; Omura H; Kumai T; Kagaya T; Ohta H; Kawashima A; Harada K; Kaneko S; Unoura M
Intern Med; 2020 Jul; 59(13):1581-1588. PubMed ID: 32269188
[TBL] [Abstract][Full Text] [Related]
40. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.
Shirabe K; Bekki Y; Gantumur D; Araki K; Ishii N; Kuno A; Narimatsu H; Mizokami M
J Gastroenterol; 2018 Jul; 53(7):819-826. PubMed ID: 29318378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
